PREFRONTAL TMS showed no clear difference in adverse effects: Leaving the study early compared with SHAM TMS (low certainty).
PREFRONTAL TBS TMS showed no clear difference in adverse effects: Leaving the study early compared with SHAM TMS (low certainty).
TEMPOROPARIETAL TMS showed no clear difference in adverse effects: Leaving the study early compared with SHAM TMS (low certainty).
The review found no eligible studies for this question.
Summary of findings: needle acupuncture showed no clear difference in frequency of adverse effects ‐ malaise ( compared with valproate (low certainty).
Summary of findings: catgut implantation at acupoints plus… showed no clear difference in frequency of adverse effects ‐ malaise ( compared with antiepileptic drugs alone (low certainty).
Summary of findings: catgut implantation at acupoints showed no clear difference in frequency of adverse effects ‐ malaise ( compared with valproate (low certainty).
Summary of findings: needle acupuncture plus valproate showed no clear difference in frequency of adverse effects ‐ malaise ( compared with valproate alone (low certainty).
It is very uncertain whether COMPARISON 2. ARIPIPRAZOLE changes adverse effects: extrapyramidal symptoms compared with QUETIAPINE (very low certainty).
COMPARISON 3. ARIPIPRAZOLE may leads to lower adverse effects: extrapyramidal symptoms compared with RISPERIDONE (low certainty).
Pre‐hospital showed no clear difference in adverse effects ‐ bleeding complications compared with in‐hospital thrombolysis (moderate certainty).
CLOZAPINE probably leads to higher adverse effects 4. Salivation ‐ too much compared with TYPICAL ANTIPSYCHOTICS (moderate certainty).
It is very uncertain whether summary of findings table ‐ Metformin + levonorgestrel (intrauterine… changes adverse effects during treatment ‐ nausea compared with levonorgestrel intrauterine system (very low certainty).
Mixed action antidepressant showed no clear difference in participants experiencing adverse effects compared with placebo (low certainty).
Buspirone showed no clear difference in participants experiencing adverse effects compared with placebo (low certainty).
Δ9‐Tetrahydrocannabinol preparation showed no clear difference in participants experiencing adverse effects compared with placebo (moderate certainty).
N‐acetylcysteine showed no clear difference in participants experiencing adverse effects compared with placebo (moderate certainty).
It is very uncertain whether selective serotonin reuptake inhibitor antidepressant changes participants experiencing adverse effects compared with placebo (very low certainty).